Dexmedetomidine effect on opioid consumption in breast reconstruction surgery

J Plast Reconstr Aesthet Surg. 2023 Oct:85:155-158. doi: 10.1016/j.bjps.2023.07.006. Epub 2023 Jul 7.

Authors

Malek Younsi¹, Jean-Philippe Rives¹, Anna Ilenko², Migena Demiri³

Affiliations

¹ Department of Anesthesia, Gustave Roussy Cancer Center, Villejuif, France.
² Department of Oncologic and Reconstructive Surgery, Gustave Roussy Cancer Center, Villejuif, France.
³ Department of Anesthesia, Gustave Roussy Cancer Center, Villejuif, France. Electronic address: [email protected].

PMID: 37494849
DOI: 10.1016/j.bjps.2023.07.006

No abstract available

Keywords: Adrenergic alpha-agonists; Breast cancer; Breast reconstruction surgery; Dexmedetomidine; Non-opioid analgesics; Postoperative pain.

MeSH terms

Analgesics, Non-Narcotic*
Analgesics, Opioid / therapeutic use
Dexmedetomidine* / therapeutic use
Double-Blind Method
Humans
Mammaplasty*
Pain, Postoperative / drug therapy
Pain, Postoperative / prevention & control

Substances

Analgesics, Opioid
Dexmedetomidine
Analgesics, Non-Narcotic